27515307|t|Progestin suppressed inflammation and cell viability of tumor necrosis factor-α -stimulated endometriotic stromal cells
27515307|a|Endometriosis is an estrogen - dependent inflammatory disease. Progestins are a first-line treatment for endometriosis via activation of pituitary progesterone receptors and suppression of systemic estrogen: a less than optimal treatment. Increasing evidence is beginning to show that progestins may also influence local endometriotic cells, which may contribute to their clinical efficacy. Endometrial stromal cells (ESC) isolated from women with endometriosis were cultured with TNF-α to simulate an inflammatory environment. ESC were treated with the progestins, medroxyprogesterone acetate (MPA), norethisterone acetate (NETA), or dienogest (DNG) and cytokine mRNA production, protein secretion, and cell viability measured. DNG, NETA, and MPA suppressed the secretion of interleukin (IL)-6, IL-8, and monocyte chemotactic protein (MCP)-1 from ESC. DNG and NETA only reduced the TNF-α -stimulated mRNA production. All three progestins suppressed TNF-α -stimulated ESC proliferation. Progestins may influence endometriotic stromal cells altering the inflammatory microenvironment and their clinical efficacy.
27515307	0	9	Progestin	T109,T121,T125	C0033306
27515307	10	33	suppressed inflammation	T080	C1515999
27515307	38	52	cell viability	T043	C1516362
27515307	56	79	tumor necrosis factor-α	T116,T129	C1456820
27515307	92	105	endometriotic	T047	C0014175
27515307	106	119	stromal cells	T025	C0162597
27515307	120	133	Endometriosis	T047	C0014175
27515307	140	148	estrogen	T109,T121,T125	C0014939
27515307	151	160	dependent	T080	C0851827
27515307	161	181	inflammatory disease	T047	C1290884
27515307	183	193	Progestins	T109,T121,T125	C0033306
27515307	200	220	first-line treatment	T061	C1708063
27515307	225	238	endometriosis	T047	C0014175
27515307	243	253	activation	T052	C1879547
27515307	257	289	pituitary progesterone receptors	T116,T192	C0034833
27515307	294	326	suppression of systemic estrogen	T061	C1535931
27515307	340	357	optimal treatment	T061	C0087111
27515307	405	415	progestins	T109,T121,T125	C0033306
27515307	425	434	influence	T077	C4054723
27515307	441	454	endometriotic	T047	C0014175
27515307	455	460	cells	T025	C0597032
27515307	492	509	clinical efficacy	T080	C3850123
27515307	511	522	Endometrial	T023	C0014180
27515307	523	536	stromal cells	T025	C0162597
27515307	538	541	ESC	T025	C0162597
27515307	557	562	women	T098	C0043210
27515307	568	581	endometriosis	T047	C0014175
27515307	587	595	cultured	T059	C1331092
27515307	601	606	TNF-α	T116,T129	C1456820
27515307	622	634	inflammatory	T169	C0333348
27515307	635	646	environment	T082	C0014406
27515307	648	651	ESC	T025	C0162597
27515307	674	684	progestins	T109,T121,T125	C0033306
27515307	686	713	medroxyprogesterone acetate	T109,T121,T125	C0065864
27515307	715	718	MPA	T109,T121,T125	C0065864
27515307	721	743	norethisterone acetate	T109,T121,T125	C0068980
27515307	745	749	NETA	T109,T121,T125	C0068980
27515307	755	764	dienogest	T109,T121,T125	C0057916
27515307	766	769	DNG	T109,T121,T125	C0057916
27515307	775	783	cytokine	T116,T129	C0079189
27515307	784	799	mRNA production	T045	C1158816
27515307	801	818	protein secretion	T043	C1159339
27515307	824	847	cell viability measured	T062	C2986858
27515307	849	852	DNG	T109,T121,T125	C0057916
27515307	854	858	NETA	T109,T121,T125	C0068980
27515307	864	867	MPA	T109,T121,T125	C0065864
27515307	883	907	secretion of interleukin	T043	C3155041
27515307	908	914	(IL)-6	T116,T129	C0021760
27515307	916	920	IL-8	T116,T129	C0079633
27515307	926	962	monocyte chemotactic protein (MCP)-1	T116,T129	C0128897
27515307	968	971	ESC	T025	C0162597
27515307	973	976	DNG	T109,T121,T125	C0057916
27515307	981	985	NETA	T109,T121,T125	C0068980
27515307	1003	1008	TNF-α	T116,T129	C1456820
27515307	1021	1036	mRNA production	T045	C1158816
27515307	1048	1058	progestins	T109,T121,T125	C0033306
27515307	1070	1075	TNF-α	T116,T129	C1456820
27515307	1088	1105	ESC proliferation	T043	C0596290
27515307	1107	1117	Progestins	T109,T121,T125	C0033306
27515307	1132	1145	endometriotic	T047	C0014175
27515307	1146	1159	stromal cells	T025	C0162597
27515307	1160	1202	altering the inflammatory microenvironment	T033	C0243095
27515307	1213	1230	clinical efficacy	T080	C3850123